{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T19:54:54Z","timestamp":1768593294816,"version":"3.49.0"},"reference-count":23,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Background\/Objectives: Understanding the biological factors that drive the behavior and clinical presentation of breast cancer (BC) skeletal metastases (SM) is critical for improving diagnostic accuracy and guiding treatment strategies. However, evidence regarding the immunohistochemical (IHC) profiles of SM and their association with radiographic characteristics and clinical features remains limited. This study aimed to evaluate the relationship between estrogen receptor (ER), progesterone receptor (PR), HER2 receptor status, and Ki-67 proliferation index with the radiographic presentation of SM in patients with BC. Methods: A total of 185 SM samples from individual BC patients were analyzed. IHC expressions of ER, PR, HER2, and Ki-67 were determined for each sample. Clinical and radiological data were retrieved from medical records. IHC profiles were compared between metastases demonstrating purely lytic versus mixed radiographic patterns. Results: Of the 185 cases, 66 exhibited a lytic pattern, and 119 demonstrated a mixed pattern. Lytic metastases showed a significantly higher rate of HER2 positivity compared with mixed lesions. The Ki-67 index was also significantly higher in lytic metastases, with a cutoff value of 25 yielding a sensitivity of 92.98% and specificity of 89.84% (positive likelihood ratio 9.16; negative likelihood ratio 0.08). No significant differences were observed between groups in ER or PR expression. Conclusions: SM from BC with a lytic radiographic presentation are more likely to exhibit HER2 positivity and a Ki-67 index above 25. Assessing the IHC status of SM may help identify patients at elevated risk for skeletal complications, including pathological fracture, and may support more tailored surgical and systemic treatment planning.<\/jats:p>","DOI":"10.3390\/diagnostics16020281","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T08:08:21Z","timestamp":1768550901000},"page":"281","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association Between Immunohistochemical Profile and Radiographic Presentation of Breast Cancer Skeletal Metastases"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5492-6149","authenticated-orcid":false,"given":"Stanislav","family":"Rajkovic","sequence":"first","affiliation":[{"name":"Institute for Orthopaedics \u201cBanjica\u201d, Medical Faculty, University of Belgrade, 11000 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1241-1029","authenticated-orcid":false,"given":"Lazar","family":"Miceta","sequence":"additional","affiliation":[{"name":"Institute for Orthopaedics \u201cBanjica\u201d, Medical Faculty, University of Belgrade, 11000 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bojan","family":"Petrovic","sequence":"additional","affiliation":[{"name":"Institute for Orthopaedics \u201cBanjica\u201d, Medical Faculty, University of Belgrade, 11000 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1036-147X","authenticated-orcid":false,"given":"Nikola","family":"Bogosavljevic","sequence":"additional","affiliation":[{"name":"Institute for Orthopaedics \u201cBanjica\u201d, Medical Faculty, University of Belgrade, 11000 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nemanja","family":"Jovanovic","sequence":"additional","affiliation":[{"name":"Institute for Orthopaedics \u201cBanjica\u201d, Medical Faculty, University of Belgrade, 11000 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8066-5701","authenticated-orcid":false,"given":"Goran","family":"Djuricic","sequence":"additional","affiliation":[{"name":"University Children\u2019s Hospital, Medical Faculty, University of Belgrade, 11000 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ljubica","family":"Simic","sequence":"additional","affiliation":[{"name":"Institute for Pathology, Medical Faculty, University of Belgrade, 11000 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jelena","family":"Sopta","sequence":"additional","affiliation":[{"name":"Institute for Pathology, Medical Faculty, University of Belgrade, 11000 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5903-0878","authenticated-orcid":false,"given":"Danilo","family":"Jeremic","sequence":"additional","affiliation":[{"name":"Institute for Orthopaedics \u201cBanjica\u201d, Medical Faculty, University of Belgrade, 11000 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,1,16]]},"reference":[{"key":"ref_1","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e1027","DOI":"10.1016\/S2214-109X(20)30215-1","article-title":"Global burden and trends in premenopausal and postmenopausal breast cancer: A population-based study","volume":"8","author":"Heer","year":"2020","journal-title":"Lancet Glob. Health"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jbo.2018.01.004","article-title":"Incidence, risk factors and prognostic characteristics of bone metastases and skeletal-related events (SREs) in breast cancer patients: A systematic review of the real-world data","volume":"11","author":"Zhang","year":"2018","journal-title":"J. Bone Oncol."},{"key":"ref_4","first-page":"98","article-title":"Diagnostic methods for detection of bone metastases","volume":"21","author":"Naza","year":"2017","journal-title":"Contemp. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/00003086-198912000-00027","article-title":"Metastatic disease in long bones. A proposed scoring system for diagnosing impending pathologic fractures","volume":"249","author":"Mirels","year":"1989","journal-title":"Clin. Orthop. Relat. Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"E1221","DOI":"10.1097\/BRS.0b013e3181e16ae2","article-title":"A Novel Classification System for Spinal Instability in Neoplastic Disease: An Evidence-Based Approach and Expert Consensus From the Spine Oncology Study Group","volume":"35","author":"Fisher","year":"2010","journal-title":"Spine"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00223-017-0362-4","article-title":"Hallmarks of Bone Metastasis","volume":"102","author":"Johnson","year":"2018","journal-title":"Calcif. Tissue Int."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3892\/ol.2020.11948","article-title":"Impact of molecular subtypes on metastatic behavior and overall survival in patients with metastatic breast cancer: A single-center study combined with a large cohort study based on the Surveillance, Epidemiology and End Results database","volume":"20","author":"Yang","year":"2020","journal-title":"Oncol. Lett."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"27990","DOI":"10.18632\/oncotarget.15856","article-title":"Breast cancer subtypes predict the preferential site of distant metastases: A SEER based study","volume":"8","author":"Wu","year":"2017","journal-title":"Oncotarget"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/tbj.12059","article-title":"Prognostic value of breast cancer subtypes, Ki-67 proliferation index, age, and pathologic tumor characteristics on breast cancer survival in Caucasian women","volume":"19","author":"Ferguson","year":"2013","journal-title":"Breast J."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Bae, S.Y., Kim, S., Lee, J.H., Lee, H.C., Lee, S.K., Kil, W.H., Kim, S.W., Lee, J.E., and Nam, S.J. (2015). Poor prognosis of single hormone receptor- positive breast cancer: Similar outcome as triple-negative breast cancer. BMC Cancer, 15.","DOI":"10.1186\/s12885-015-1121-4"},{"key":"ref_12","first-page":"24","article-title":"Skeletne metastaze karcinoma dojke\u2013uticaj hormonskih i HER2 receptora","volume":"75","author":"Rajkovic","year":"2024","journal-title":"Med. Podml."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1200\/JCO.2009.25.6529","article-title":"American Society of Clinical Oncology\/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer","volume":"28","author":"Hammond","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1200\/JCO.2013.50.9984","article-title":"Recommendations for human epidermal growth factor receptor two testing in breast cancer: American Society of Clinical Oncology\/College of American Pathologists clinical practice guideline update","volume":"31","author":"Wolff","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/1097-0142(19830801)52:3<479::AID-CNCR2820520317>3.0.CO;2-O","article-title":"Variation in receptor status between primary and metastatic breast cancer","volume":"52","author":"Holdaway","year":"1983","journal-title":"Cancer"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1200\/JCO.2011.37.2482","article-title":"Clinically used breast cancer markers such as estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 are unstable throughout tumor progression","volume":"30","author":"Karlsson","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"ref_17","unstructured":"Lindstrom, L., Howell, S., and Astrom, G. (2010). Controversies in the management of metastatic breast cancer: Biologic evaluation of breast cancer\u2013should metastases be biopsied?. American Society of Clinical Oncology 2010 Educational Book, American Society of Clinical Oncology."},{"key":"ref_18","first-page":"338","article-title":"Bone metastasis: Evaluation of 1100 patients with breast cancer","volume":"14","year":"2021","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9","article-title":"The Ki-67 protein: From the known and the unknown","volume":"182","author":"Scholzen","year":"2000","journal-title":"J. Cell. Physiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1093\/jnci\/djr393","article-title":"Assessment of Ki67 in breast cancer: Recommendations from the International Ki67 in Breast Cancer working group","volume":"103","author":"Dowsett","year":"2011","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Hashmi, A.A., Hashmi, K.A., Irfan, M., Khan, S.M., Edhi, M.M., Ali, J.P., Hashmi, S.K., Asif, H., Faridi, N., and Khan, A. (2019). Ki67 index in intrinsic breast cancer subtypes and its association with prognostic parameters. BMC Res. Notes, 12.","DOI":"10.1186\/s13104-019-4653-x"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s10585-016-9830-x","article-title":"Comparison of immunophenotypes of primary breast carcinomas and multiple corresponding distant metastases: An autopsy study of 25 patients","volume":"34","author":"Szekely","year":"2017","journal-title":"Clin. Exp. Metastasis"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1002\/ijc.34605","article-title":"Higher rate of progesterone receptor positivity in skeletal metastases of breast cancer with a pathological fracture vs those without fracture","volume":"153","author":"Rajkovic","year":"2023","journal-title":"Int. J. Cancer"}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/2\/281\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T08:25:38Z","timestamp":1768551938000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/2\/281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,16]]},"references-count":23,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["diagnostics16020281"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics16020281","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,16]]}}}